Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (NIH R01NS097808)
Foundation for Angelman Syndrome Therapeutics
Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD103526)
Received: 28 August 2020
Accepted: 18 January 2021
First Online: 6 February 2021
Ethical approval and consent to participate
: No humans were involved in this study. Animal research was conducted under the UC Davis IACUC #21,779 (PI Silverman).
: Not applicable.